What question did this study set out to answer?

The aim is to establish a sensitive and specific immunofluorescence assay for detecting anti-cN1A autoantibodies in inclusion body myositis.

April 1, 2026Open Access

A New Immunofluorescence Assay Allows the Sensitive Detection of Anti‐Cytosolic 5′‐Nucleotidase 1A Autoantibodies

Key Points

The aim is to establish a sensitive and specific immunofluorescence assay for detecting anti-cN1A autoantibodies in inclusion body myositis.
Developed an immunofluorescence assay utilizing GFP-cN1A for detection.
Analyzed sera from patients diagnosed with inclusion body myositis.
Compared sensitivity and specificity with alternative assays.
The new assay showed higher sensitivity for detecting anti-cN1A autoantibodies than other assays.
No loss of specificity was reported compared to alternative methods.

Abstract

Anti-cN1A autoantibodies are helpful for diagnosing inclusion body myositis (IBM). We have developed an immunofluorescence assay based on the perinuclear accumulation of GFP-cN1A. The analysis of patient sera indicated that this assay shows a higher sensitivity for anti-cN1A in IBM compared to alternative assays, without loss of specificity.

A New Immunofluorescence Assay Allows the Sensitive Detection of Anti‐Cytosolic 5′‐Nucleotidase 1A Autoantibodies

Key Points

Abstract

Cite This Study